[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Live Attenuated Vaccine Sales Market Report 2017

December 2017 | 103 pages | ID: G8E422841B4EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Live Attenuated Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Live Attenuated Vaccine for these regions, from 2012 to 2022 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Live Attenuated Vaccine market competition by top manufacturers/players, with Live Attenuated Vaccine sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Astellas Pharma (Japan)
  • CSL Limited (Australia)
  • Emergent BioSolutions (U.S.)
  • GlaxoSmithKline (U.K.)
  • Johnson & Johnson (U.S.)
  • MedImmune (U.S.)
  • Merck & Co (U.S.)
  • Pfizer (U.S.)
  • Sanofi Pasteur (France)
  • Serum Institute of India Pvt (India)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • By End User
    • Pediatrics
    • Adults
  • By Disease Indication
    • Pneumococcal
    • Influenza
    • HPV
    • Hepatitis
    • Rotavirus
    • DTP
    • Polio
    • MMR
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Medical Center
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Live Attenuated Vaccine Sales Market Report 2017

1 LIVE ATTENUATED VACCINE MARKET OVERVIEW

1.1 Product Overview and Scope of Live Attenuated Vaccine
1.2 Classification of Live Attenuated Vaccine by Product Category
  1.2.1 Global Live Attenuated Vaccine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Live Attenuated Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Pediatrics
  1.2.4 Adults
1.3 Global Live Attenuated Vaccine Market by Application/End Users
  1.3.1 Global Live Attenuated Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Center
  1.3.4 Others
1.4 Global Live Attenuated Vaccine Market by Region
  1.4.1 Global Live Attenuated Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Live Attenuated Vaccine Status and Prospect (2012-2022)
  1.4.3 China Live Attenuated Vaccine Status and Prospect (2012-2022)
  1.4.4 Europe Live Attenuated Vaccine Status and Prospect (2012-2022)
  1.4.5 Japan Live Attenuated Vaccine Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Live Attenuated Vaccine Status and Prospect (2012-2022)
  1.4.7 India Live Attenuated Vaccine Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Live Attenuated Vaccine (2012-2022)
  1.5.1 Global Live Attenuated Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 Global Live Attenuated Vaccine Revenue and Growth Rate (2012-2022)

2 GLOBAL LIVE ATTENUATED VACCINE COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Live Attenuated Vaccine Market Competition by Players/Suppliers
  2.1.1 Global Live Attenuated Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Live Attenuated Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Live Attenuated Vaccine (Volume and Value) by Type
  2.2.1 Global Live Attenuated Vaccine Sales and Market Share by Type (2012-2017)
  2.2.2 Global Live Attenuated Vaccine Revenue and Market Share by Type (2012-2017)
2.3 Global Live Attenuated Vaccine (Volume and Value) by Region
  2.3.1 Global Live Attenuated Vaccine Sales and Market Share by Region (2012-2017)
  2.3.2 Global Live Attenuated Vaccine Revenue and Market Share by Region (2012-2017)
2.4 Global Live Attenuated Vaccine (Volume) by Application

3 UNITED STATES LIVE ATTENUATED VACCINE (VOLUME, VALUE AND SALES PRICE)

3.1 United States Live Attenuated Vaccine Sales and Value (2012-2017)
  3.1.1 United States Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
  3.1.2 United States Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
  3.1.3 United States Live Attenuated Vaccine Sales Price Trend (2012-2017)
3.2 United States Live Attenuated Vaccine Sales Volume and Market Share by Players
3.3 United States Live Attenuated Vaccine Sales Volume and Market Share by Type
3.4 United States Live Attenuated Vaccine Sales Volume and Market Share by Application

4 CHINA LIVE ATTENUATED VACCINE (VOLUME, VALUE AND SALES PRICE)

4.1 China Live Attenuated Vaccine Sales and Value (2012-2017)
  4.1.1 China Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
  4.1.2 China Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
  4.1.3 China Live Attenuated Vaccine Sales Price Trend (2012-2017)
4.2 China Live Attenuated Vaccine Sales Volume and Market Share by Players
4.3 China Live Attenuated Vaccine Sales Volume and Market Share by Type
4.4 China Live Attenuated Vaccine Sales Volume and Market Share by Application

5 EUROPE LIVE ATTENUATED VACCINE (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Live Attenuated Vaccine Sales and Value (2012-2017)
  5.1.1 Europe Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
  5.1.2 Europe Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Live Attenuated Vaccine Sales Price Trend (2012-2017)
5.2 Europe Live Attenuated Vaccine Sales Volume and Market Share by Players
5.3 Europe Live Attenuated Vaccine Sales Volume and Market Share by Type
5.4 Europe Live Attenuated Vaccine Sales Volume and Market Share by Application

6 JAPAN LIVE ATTENUATED VACCINE (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Live Attenuated Vaccine Sales and Value (2012-2017)
  6.1.1 Japan Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
  6.1.2 Japan Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Live Attenuated Vaccine Sales Price Trend (2012-2017)
6.2 Japan Live Attenuated Vaccine Sales Volume and Market Share by Players
6.3 Japan Live Attenuated Vaccine Sales Volume and Market Share by Type
6.4 Japan Live Attenuated Vaccine Sales Volume and Market Share by Application

7 SOUTHEAST ASIA LIVE ATTENUATED VACCINE (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Live Attenuated Vaccine Sales and Value (2012-2017)
  7.1.1 Southeast Asia Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Live Attenuated Vaccine Sales Price Trend (2012-2017)
7.2 Southeast Asia Live Attenuated Vaccine Sales Volume and Market Share by Players
7.3 Southeast Asia Live Attenuated Vaccine Sales Volume and Market Share by Type
7.4 Southeast Asia Live Attenuated Vaccine Sales Volume and Market Share by Application

8 INDIA LIVE ATTENUATED VACCINE (VOLUME, VALUE AND SALES PRICE)

8.1 India Live Attenuated Vaccine Sales and Value (2012-2017)
  8.1.1 India Live Attenuated Vaccine Sales and Growth Rate (2012-2017)
  8.1.2 India Live Attenuated Vaccine Revenue and Growth Rate (2012-2017)
  8.1.3 India Live Attenuated Vaccine Sales Price Trend (2012-2017)
8.2 India Live Attenuated Vaccine Sales Volume and Market Share by Players
8.3 India Live Attenuated Vaccine Sales Volume and Market Share by Type
8.4 India Live Attenuated Vaccine Sales Volume and Market Share by Application

9 GLOBAL LIVE ATTENUATED VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Astellas Pharma (Japan)
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Live Attenuated Vaccine Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Astellas Pharma (Japan) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 CSL Limited (Australia)
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Live Attenuated Vaccine Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 CSL Limited (Australia) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Emergent BioSolutions (U.S.)
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Live Attenuated Vaccine Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline (U.K.)
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Live Attenuated Vaccine Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Johnson & Johnson (U.S.)
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Live Attenuated Vaccine Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 MedImmune (U.S.)
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Live Attenuated Vaccine Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 MedImmune (U.S.) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Merck & Co (U.S.)
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Live Attenuated Vaccine Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Merck & Co (U.S.) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Pfizer (U.S.)
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Live Attenuated Vaccine Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Pfizer (U.S.) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 Sanofi Pasteur (France)
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Live Attenuated Vaccine Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Sanofi Pasteur (France) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Serum Institute of India Pvt (India)
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Live Attenuated Vaccine Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview

10 LIVE ATTENUATED VACCINE MAUFACTURING COST ANALYSIS

10.1 Live Attenuated Vaccine Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Live Attenuated Vaccine
10.3 Manufacturing Process Analysis of Live Attenuated Vaccine

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Live Attenuated Vaccine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Live Attenuated Vaccine Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL LIVE ATTENUATED VACCINE MARKET FORECAST (2017-2022)

14.1 Global Live Attenuated Vaccine Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Live Attenuated Vaccine Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Live Attenuated Vaccine Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Live Attenuated Vaccine Price and Trend Forecast (2017-2022)
14.2 Global Live Attenuated Vaccine Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Live Attenuated Vaccine Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Live Attenuated Vaccine Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Live Attenuated Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Live Attenuated Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Live Attenuated Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Live Attenuated Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Live Attenuated Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Live Attenuated Vaccine Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Live Attenuated Vaccine Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Live Attenuated Vaccine Sales Forecast by Type (2017-2022)
  14.3.2 Global Live Attenuated Vaccine Revenue Forecast by Type (2017-2022)
  14.3.3 Global Live Attenuated Vaccine Price Forecast by Type (2017-2022)
14.4 Global Live Attenuated Vaccine Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Live Attenuated Vaccine
Figure Global Live Attenuated Vaccine Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Live Attenuated Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Pediatrics Product Picture
Figure Adults Product Picture
Figure Global Live Attenuated Vaccine Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Live Attenuated Vaccine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Live Attenuated Vaccine Market Size (Million USD) by Regions (2012-2022)
Figure United States Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Live Attenuated Vaccine Sales Volume (K Pcs) (2012-2017)
Table Global Live Attenuated Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Live Attenuated Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Live Attenuated Vaccine Sales Share by Players/Suppliers
Figure 2017 Live Attenuated Vaccine Sales Share by Players/Suppliers
Figure Global Live Attenuated Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Live Attenuated Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Live Attenuated Vaccine Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Live Attenuated Vaccine Revenue Share by Players
Table 2017 Global Live Attenuated Vaccine Revenue Share by Players
Table Global Live Attenuated Vaccine Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Live Attenuated Vaccine Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Live Attenuated Vaccine by Type (2012-2017)
Figure Global Live Attenuated Vaccine Sales Growth Rate by Type (2012-2017)
Table Global Live Attenuated Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Live Attenuated Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Live Attenuated Vaccine by Type (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Growth Rate by Type (2012-2017)
Table Global Live Attenuated Vaccine Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Live Attenuated Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Live Attenuated Vaccine by Region (2012-2017)
Figure Global Live Attenuated Vaccine Sales Growth Rate by Region in 2016
Table Global Live Attenuated Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Live Attenuated Vaccine Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Live Attenuated Vaccine by Region (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Growth Rate by Region in 2016
Table Global Live Attenuated Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Live Attenuated Vaccine Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Live Attenuated Vaccine by Region (2012-2017)
Figure Global Live Attenuated Vaccine Revenue Market Share by Region in 2016
Table Global Live Attenuated Vaccine Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Live Attenuated Vaccine Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Live Attenuated Vaccine by Application (2012-2017)
Figure Global Live Attenuated Vaccine Sales Market Share by Application (2012-2017)
Figure United States Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Live Attenuated Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Live Attenuated Vaccine Sales Volume (K Pcs) by Players (2012-2017)
Table United States Live Attenuated Vaccine Sales Volume Market Share by Players (2012-2017)
Figure United States Live Attenuated Vaccine Sales Volume Market Share by Players in 2016
Table United States Live Attenuated Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table United States Live Attenuated Vaccine Sales Volume Market Share by Type (2012-2017)
Figure United States Live Attenuated Vaccine Sales Volume Market Share by Type in 2016
Table United States Live Attenuated Vaccine Sales Volume (K Pcs) by Application (2012-2017)
Table United States Live Attenuated Vaccine Sales Volume Market Share by Application (2012-2017)
Figure United States Live Attenuated Vaccine Sales Volume Market Share by Application in 2016
Figure China Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Live Attenuated Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table China Live Attenuated Vaccine Sales Volume (K Pcs) by Players (2012-2017)
Table China Live Attenuated Vaccine Sales Volume Market Share by Players (2012-2017)
Figure China Live Attenuated Vaccine Sales Volume Market Share by Players in 2016
Table China Live Attenuated Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table China Live Attenuated Vaccine Sales Volume Market Share by Type (2012-2017)
Figure China Live Attenuated Vaccine Sales Volume Market Share by Type in 2016
Table China Live Attenuated Vaccine Sales Volume (K Pcs) by Application (2012-2017)
Table China Live Attenuated Vaccine Sales Volume Market Share by Application (2012-2017)
Figure China Live Attenuated Vaccine Sales Volume Market Share by Application in 2016
Figure Europe Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Live Attenuated Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Live Attenuated Vaccine Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Live Attenuated Vaccine Sales Volume Market Share by Players (2012-2017)
Figure Europe Live Attenuated Vaccine Sales Volume Market Share by Players in 2016
Table Europe Live Attenuated Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Live Attenuated Vaccine Sales Volume Market Share by Type (2012-2017)
Figure Europe Live Attenuated Vaccine Sales Volume Market Share by Type in 2016
Table Europe Live Attenuated Vaccine Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Live Attenuated Vaccine Sales Volume Market Share by Application (2012-2017)
Figure Europe Live Attenuated Vaccine Sales Volume Market Share by Application in 2016
Figure Japan Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Live Attenuated Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Live Attenuated Vaccine Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Live Attenuated Vaccine Sales Volume Market Share by Players (2012-2017)
Figure Japan Live Attenuated Vaccine Sales Volume Market Share by Players in 2016
Table Japan Live Attenuated Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Live Attenuated Vaccine Sales Volume Market Share by Type (2012-2017)
Figure Japan Live Attenuated Vaccine Sales Volume Market Share by Type in 2016
Table Japan Live Attenuated Vaccine Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Live Attenuated Vaccine Sales Volume Market Share by Application (2012-2017)
Figure Japan Live Attenuated Vaccine Sales Volume Market Share by Application in 2016
Figure Southeast Asia Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Live Attenuated Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Live Attenuated Vaccine Sales Volume Market Share by Players in 2016
Table Southeast Asia Live Attenuated Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Live Attenuated Vaccine Sales Volume Market Share by Type in 2016
Table Southeast Asia Live Attenuated Vaccine Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Live Attenuated Vaccine Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Live Attenuated Vaccine Sales Volume Market Share by Application in 2016
Figure India Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Live Attenuated Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table India Live Attenuated Vaccine Sales Volume (K Pcs) by Players (2012-2017)
Table India Live Attenuated Vaccine Sales Volume Market Share by Players (2012-2017)
Figure India Live Attenuated Vaccine Sales Volume Market Share by Players in 2016
Table India Live Attenuated Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table India Live Attenuated Vaccine Sales Volume Market Share by Type (2012-2017)
Figure India Live Attenuated Vaccine Sales Volume Market Share by Type in 2016
Table India Live Attenuated Vaccine Sales Volume (K Pcs) by Application (2012-2017)
Table India Live Attenuated Vaccine Sales Volume Market Share by Application (2012-2017)
Figure India Live Attenuated Vaccine Sales Volume Market Share by Application in 2016
Table Astellas Pharma (Japan) Basic Information List
Table Astellas Pharma (Japan) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales Global Market Share (2012-2017
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Revenue Global Market Share (2012-2017)
Table CSL Limited (Australia) Basic Information List
Table CSL Limited (Australia) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CSL Limited (Australia) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure CSL Limited (Australia) Live Attenuated Vaccine Sales Global Market Share (2012-2017
Figure CSL Limited (Australia) Live Attenuated Vaccine Revenue Global Market Share (2012-2017)
Table Emergent BioSolutions (U.S.) Basic Information List
Table Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Global Market Share (2012-2017
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline (U.K.) Basic Information List
Table GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Global Market Share (2012-2017
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Revenue Global Market Share (2012-2017)
Table Johnson & Johnson (U.S.) Basic Information List
Table Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Global Market Share (2012-2017
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Revenue Global Market Share (2012-2017)
Table MedImmune (U.S.) Basic Information List
Table MedImmune (U.S.) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MedImmune (U.S.) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure MedImmune (U.S.) Live Attenuated Vaccine Sales Global Market Share (2012-2017
Figure MedImmune (U.S.) Live Attenuated Vaccine Revenue Global Market Share (2012-2017)
Table Merck & Co (U.S.) Basic Information List
Table Merck & Co (U.S.) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales Global Market Share (2012-2017
Figure Merck & Co (U.S.) Live Attenuated Vaccine Revenue Global Market Share (2012-2017)
Table Pfizer (U.S.) Basic Information List
Table Pfizer (U.S.) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer (U.S.) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Pfizer (U.S.) Live Attenuated Vaccine Sales Global Market Share (2012-2017
Figure Pfizer (U.S.) Live Attenuated Vaccine Revenue Global Market Share (2012-2017)
Table Sanofi Pasteur (France) Basic Information List
Table Sanofi Pasteur (France) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales Global Market Share (2012-2017
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Revenue Global Market Share (2012-2017)
Table Serum Institute of India Pvt (India) Basic Information List
Table Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Global Market Share (2012-2017
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Live Attenuated Vaccine
Figure Manufacturing Process Analysis of Live Attenuated Vaccine
Figure Live Attenuated Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Live Attenuated Vaccine Major Players in 2016
Table Major Buyers of Live Attenuated Vaccine
Table Distributors/Traders List
Figure Global Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Live Attenuated Vaccine Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Live Attenuated Vaccine Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Regions in 2022
Table Global Live Attenuated Vaccine Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Live Attenuated Vaccine Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Live Attenuated Vaccine Revenue Market Share Forecast by Regions in 2022
Figure United States Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Live Attenuated Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Live Attenuated Vaccine Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Live Attenuated Vaccine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Live Attenuated Vaccine Revenue Market Share Forecast by Type (2017-2022)
Table Global Live Attenuated Vaccine Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Live Attenuated Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Live Attenuated Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories